fasudil has been researched along with Demyelinating Diseases in 2 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, ZB | 1 |
| Han, QX | 1 |
| Wang, Q | 1 |
| Song, LJ | 1 |
| Chu, GG | 1 |
| Guo, MF | 1 |
| Chai, Z | 1 |
| Yu, JZ | 1 |
| Xiao, BG | 1 |
| Li, XY | 1 |
| Ma, CG | 1 |
| Baer, AS | 1 |
| Syed, YA | 1 |
| Kang, SU | 1 |
| Mitteregger, D | 1 |
| Vig, R | 1 |
| Ffrench-Constant, C | 1 |
| Franklin, RJ | 1 |
| Altmann, F | 1 |
| Lubec, G | 1 |
| Kotter, MR | 1 |
2 other studies available for fasudil and Demyelinating Diseases
| Article | Year |
|---|---|
Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Brain-Derived Neurotrophic Factor; Cell Diff | 2021 |
Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Animals, Newborn; Carbazoles; Cell Different | 2009 |